Soy-tibolone combination-Effect on lipids in postmenopausal monkeys and women

Maturitas

Volumn 60, Issue 3-4, 2008, Pages 216-222

  Appt, Susan E ^a   Törmälä, Riina ^b   Franke, Adrian A ^c   Mikkola, Tomi S ^b   Tikkanen, Matti J ^b   Ylikorkala, Olavi ^b   Clarkson, Thomas B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Cardiovascular; Lipids; Menopause; Monkeys; Soy; Tibolone

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SOYBEAN PROTEIN; TIBOLONE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FEMALE; MONKEY; NONHUMAN; POSTMENOPAUSE; SOYBEAN; THERAPY EFFECT;

ANIMALS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; ISOFLAVONES; MACACA FASCICULARIS; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE;

ANIMALIA; MACACA FASCICULARIS;

EID: 52149106456     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.06.003     Document Type: Article

References (37)

1. Campisi R., and Marengo F.D. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev 25 (2007) 132-145
2. Kloosterboer H.J. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76 (2001) 231-238
3. Verheu H.A.M., Timmer C.J., van Iersel M.L.P.S., Delbressine L.P.C., and Kloosterboer H.J. Pharmacokinetic parameters of tibolone and metabolites in plasma, urine, feces, and bile from ovariectomized cynomolgus monkeys after a single dose or multiple doses of tibolone. Drug Metab Distribution 35 (2007) 1112-1118
4. Christodoulakos G.E., Lambrinoudaki I.V., Economou E.V., et al. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma. J Cardiovasc Pharmacol 47 (2006) 542-548
5. Kalogeropoulos S., Petrogiannopoulos C., Gagos S., Kampas N., and Kalogeropoulos G. The influence of 5-year therapy with tibolone on the lipid profile in postmenopausal women with mild hypercholesterolemia. Gynecol Endocrinol 18 (2004) 227-232
6. Bjarnason N.H., Bjarnason K., Haarbo J., Bennick H.J., and Christiansen C. Tibolone: influence on markers of cardiovascular disease. J Clin Endocrinol Metab 82 (1997) 1752-1756
7. Crona N., Silfverstolpe G., and Samsoie G. A double-blind cross-over study on the effects of Org OD 14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women. Acta Endocrinol 102 (1983) 451-455
8. Clarkson T.B., Anthony M.S., and Wagner J.D. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab 86 (2001) 5396-5404
9. Clarkson T.B., and Appt S.E. Soy phytoestrogens (isoflavones) for estrogen replacement therapy-strengths and weaknesses. In: Schneider H.P.G. (Ed). Menopause - The State of the Art - in Research and Management: Proceedings of the 10th World Congress on the Menopause (2003), Parthenon Publishing, Berlin, Germany, London, UK 287-294
10. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., and Winston M. Soy protein, isoflavones and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113 (2006) 1034-1044
11. Franke A.A., Custer L.J., Wilkens L.R., et al. Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 777 (2002) 45-59
12. Burstein M., and Samaille J. On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins. Clin Chim Acta 5 (1960) 609
13. Manual of laboratory operations: lipid research clinics program, vol. 1. Lipid and lipoprotein analysis. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health, Education, and Welfare Publication NIH; 1974, p. 75-268.
14. Törmälä R., Appt S.E., Clarkson T.B., Tikkanen M.J., Ylikorkala O., and Mikkola T.S. Individual differences in equol production capability modulate blood pressure in tibolone treated postmenopausal women. Climacteric 10 (2007) 471-479
15. Wang G.J., Lapcik O., Hampl R., et al. Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 65 (2000) 339-348
16. Nikander E., Kilkkinen A., Metsä-Heikkilä M., et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 101 (2003) 1213-1220
17. Nikander E., Tiitinen A., Laitinen K., Tikkanen M., and Ylikorkala O. Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. J Clin Endocrinol Metab 89 (2004) 3567-3572
18. Clarkson T.B., Anthony M.S., and Morgan T.M. Inhibition of postmenopausal atherosclerosis progression-a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 86 (2001) 41-47
19. Turley S.D., Spady D.K., and Dietschy J.M. Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey. J Lipid Res 36 (1995) 67-79
20. Klein R.L., and Rudel L.L. Cholesterol absorption and transport in thoracic duct lymph lipoproteins of nonhuman primates. Effect of dietary cholesterol level. J Lipid Res 24 (1983) 343-356
21. Manning P.J., Clarkson T.B., and Lofland H.B. Cholesterol absorption, turnover, and excretion in hypercholesterolemic rhesus monkeys. Exp Mol Pathol 14 (1971) 75-89
22. McNamara D.J. Dietary cholesterol and atherosclerosis. Biochim Biophys Acta 1529 (2000) 310-320
23. Gu L., House S.E., Prior R.L., et al. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr 136 (2006) 1215-1221
24. Lampe J.W., Karr S.C., Hutchins A.M., and Slavin J.L. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217 (1998) 335-339
25. Setchell K.D., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132 (2002) 3577-3584
26. Appt S.E., Clarkson T.B., Register T.C., and Chen H. Dietary equol does not reproduce effects of dietary soy on cardiovascular disease risk variables; observations from postmenopausal monkeys (16th Annual Meeting, San Diego, September 28-October 1, 2005). Menopause 12 (2005) 784
27. Törmälä R., Appt S.E., Clarkson T.B., et al. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect of soy supplementation. Atherosclerosis 198 (2008) 174-178
28. Dewell A., Hollenbeck P.L., and Hollenbeck C.B. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab 91 (2006) 772-780
29. Bots M.L., Evans G.W., Riley W., et al. The effect of tibolone and continuous combined conjugated equine estrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: The Osteoporosis Prevention and Arterial Effects of Tibolone (OPAL) Study. Eur Heart J 27 (2006) 746-755
30. Clarkson T.B. Does tibolone exacerbate atherosclerosis?. Eur Heart J 27 (2006) 635-637 [editorial]
31. Nestel P.J., Yamashita T., Sasahara T., et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 17 (1997) 3392-3398
32. van der Schouw Y.T., Pijpe A., Lebrun C.E., et al. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler Thromb Vasc Biol 22 (2002) 1316-1322
33. Tikkanen M.J., Wahala K., Ojala S., Vihma V., and Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci 95 (1998) 3106-3110
34. Samman S., Lyons Wall P.M., Chan G.S., Smith S.J., and Petocz P. The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147 (1999) 277-283
35. Jenkins D.J., Kendall C.W., Garsetti M., et al. Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity-a controlled crossover trial. Metabolism 49 (2000) 537-543
36. Jenkins D.J., Kendall C.W., Vidgen E., et al. Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism 49 (2000) 1496-1500
37. Wiseman H., O'Reilly J.D., Adlercreutz H., et al. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72 (2000) 395-400